Croma-Pharma Overview
- Year Founded
-
1976
- Status
-
Acquired/Merged
- Employees
-
400
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
4
- Investments
-
9
Croma-Pharma General Information
Description
Manufacturer of anti-aging pharmaceutical products focused on minimally invasive aesthetic medicine. The company's anti-aging pharmaceutical products include non-invasive and minimally-invasive aesthetic dermatology, princess injectables and skincare, skin masks, serums, intradermal fillers, lifting thread and personalized cell therapy, thereby improving patient well-being with easy-to-use products.
Contact Information
Website
www.cromapharma.com(Operating Subsidiary)
Corporate Office
- Industriezeile 6
- Leobendorf, 2100
- Austria
Corporate Office
- Industriezeile 6
- Leobendorf, 2100
- Austria
Croma-Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Croma-Pharma Patents
Croma-Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026190225-A1 | Sterile composition comprising a hyaluronan component | Pending | 12-Mar-2025 | ||
| WO-2026185429-A1 | A sclerosing agent and a water-soluble-cellulose for the use in sclerotherapy for a reticular or a spider vein | Pending | 06-Mar-2025 | ||
| US-20260263656-A1 | Novel sclerotherapy of venous blood vessels | Pending | 06-Mar-2025 | ||
| US-12642884-B1 | Sclerotherapy of venous blood vessels | Active | 06-Mar-2025 | ||
| CA-203397-S | Packaging box with viewing window | Active | 10-Jul-2020 |
Croma-Pharma Signals
Croma-Pharma Investments & Acquisitions (9)
Croma-Pharma’s most recent deal was a Joint Venture with Novaestiq Aesthetics. The deal was made on 01-Jan-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Novaestiq Aesthetics | 01-Jan-2021 | Joint Venture | Personal Products | ||
| International Aesthetic Biotech | 15-Sep-2020 | Joint Venture | Distributors (Healthcare) | ||
| Orlicom | 23-Sep-2019 | Merger/Acquisition | Distributors/Wholesale | ||
| Hugel America | 05-Sep-2018 | Joint Venture | Other Consumer Non-Durables | ||
| SunCro Aesthetics & Cosmetic International | 13-Jun-2017 | Joint Venture | Pharmaceuticals |
Croma-Pharma Exits (1)
Croma-Pharma’s most recent exit was on 01-Jan-2021 from Novaestiq Aesthetics. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Novaestiq Aesthetics | 01-Jan-2021 | Completed |
|
Croma-Pharma Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Croma Deutschland | Munich, Germany | 2016 | |
| Croma Pharma | Warsaw, Poland | 2013 | |
| Xcelens | Mezzovico-Vira, Switzerland | 2004 |
Croma-Pharma FAQs
-
When was Croma-Pharma founded?
Croma-Pharma was founded in 1976.
-
Where is Croma-Pharma headquartered?
Croma-Pharma is headquartered in Leobendorf, Austria.
-
What is the size of Croma-Pharma?
Croma-Pharma has 400 total employees.
-
What industry is Croma-Pharma in?
Croma-Pharma’s primary industry is Personal Products.
-
Is Croma-Pharma a private or public company?
Croma-Pharma is a Private company.
-
What is Croma-Pharma’s current revenue?
The current revenue for Croma-Pharma is .
-
How much funding has Croma-Pharma raised over time?
Croma-Pharma has raised $44.5M.
-
Who acquired Croma-Pharma?
Croma-Pharma was acquired by STADA Arzneimittel.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process